Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a 130-kD member of the
immunoglobulin (Ig) superfamily that is expressed on the surface of circulating platelets …

The potential of CD31 as a therapeutic target in atherosclerosis has been considered ever
since its cloning in the 1990s, but the exact role played by this molecule in the biologic …

Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is a member of the
immunoglobulin (Ig) superfamily that has distinctive features of an immunoreceptor based …

CD31 (platelet endothelial adhesion molecule, PECAM-1) is generally regarded to be the
most sensitive and specific endothelial marker in paraffin sections. We have recently …

Inflammation and genetics are both prominent mechanisms in the pathogenesis of
atherosclerosis and arterial thrombosis. Accordingly, a number of population studies have …

Background Patients suffering from squamous cell carcinoma of the larynx (LSCC) with
lymphatic metastasis have a relatively poor prognosis and often require radical therapeutic …

Objectives This review summarizes recent developments in platelet biology relevant to
neuroinflammatory disorders. Multiple sclerosis (MS) is taken as the" Poster Child" of these …

The endothelium represents an important therapeutic target for containment of oxidative
stress, thrombosis and inflammation involved in a plethora of acute and chronic conditions …

Wound healing is a complex and meticulously orchestrated process involving multiple
phases and cellular interactions. This narrative review explores the intricate mechanisms …

Platelet endothelial cell adhesion molecule‐1 (PECAM‐1, CD31) is a 130‐kDa protein,
which plays a significant role in the adhesion cascade. It is therefore involved in leucocyte …